Lucid Diagnostics Inc.

NASDAQ:LUCD

0.945 (USD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12018 Q4
Revenue 0.9761.0011.040.7830.1590.4460.1120.07600.1890.30.20000000
Cost of Revenue 1.8432.1572.0861.6341.5491.3381.6181.6260.7040.3690.4410.14400.00300000
Gross Profit -0.867-1.156-1.046-0.851-1.39-0.892-1.506-1.55-0.704-0.18-0.1410.056-0-0.00300000
Gross Profit Ratio -0.888-1.155-1.006-1.087-8.742-2-13.446-20.3950-0.952-0.4690.2790000000
Reseach & Development Expenses 1.3721.5011.9181.6151.8272.2822.4422.7043.442.8813.4822.191.8731.7521.8261.2160.8661.5340.645
General & Administrative Expenses 4.8674.074.2054.323.836.5115.4625.667.3115.7182.3584.3763.1221.2120.9050.8050.4440.6830.417
Selling & Marketing Expenses 4.214.1944.4083.8374.0324.1275.0133.933.8733.3185.260.9181.0210.6890.6330.335000
SG&A 8.9538.1358.4898.1577.86210.63810.4759.5911.1849.0367.6184.3764.1431.9010.9050.8050.4440.6830.417
Other Expenses 0.5993720.54-3.0215050.5050.5050.5050-0.1730833,7750000000
Operating Expenses 10.3259.63610.40710.27710.19413.42513.42212.79914.62411.91711.16.5666.0163.6532.7312.0221.312.2171.062
Operating Income -11.192-10.792-11.453-11.128-11.584-14.317-14.928-14.349-14.624-12.097-11.24-6.51-6.016-3.653-2.731-2.022-1.31-2.217-1.062
Operating Income Ratio -11.467-10.781-11.013-14.212-72.855-32.101-133.286-188.8030-64.005-37.468-32.5490000000
Total Other Income Expenses Net 0.1870.180.623-3.0470.29-1.930.17300.004-0.173-0.065-0.447-0.147000000
Income Before Tax -11.005-10.612-10.83-14.208-11.381-16.247-14.928-14.349-14.624-12.27-11.306-6.957-6.163-3.653-2.731-2.022-1.31-2.217-1.062
Income Before Tax Ratio -11.276-10.601-10.413-18.146-71.579-36.428-133.286-188.8030-64.921-37.685-34.7830000000
Income Tax Expense 07,496-1,960.351-2.8720.2231,963-0.1730.5660.0040.1730.0650.4470.1470-2.731-2.022000
Net Income -11.005-10.612-10.83-14.208-11.381-1,979.247-14.755-14.349-14.624-12.443-11.306-6.957-6.163-3.653-2.731-2.022-1.31-2.217-1.062
Net Income Ratio -11.276-10.601-10.413-18.146-71.579-4,437.774-131.741-188.8030-65.836-37.685-34.7830000000
EPS -0.23-0.24-0.26-0.34-0.27-48.31-0.4-0.39-0.41-0.35-0.31-0.19-0.17-0.099-0.074-0.055-0.093-0.16-0.075
EPS Diluted -0.23-0.24-0.26-0.34-0.27-48.31-0.4-0.39-0.41-0.35-0.31-0.19-0.17-0.099-0.074-0.055-0.093-0.16-0.075
EBITDA -10.963-10.291-10.824-13.408-10.815-15.602-14.313-13.756-13.92-12.073-11.24-6.509-6.016-3.65-2.731-2.022000
EBITDA Ratio -11.233-10.281-10.408-17.124-68.019-34.982-127.795-1810-63.878-37.466-32.5470000000